BioSpace News Archive

Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that Mike Raab, president and chief executive officer of Ardelyx, will present a company overview at the Ladenburg Thalmann Conference on Tuesday, September 24, 2019 at 9:00 a.m. ET in New York City.

ACADIA Pharmaceuticals Inc. announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $250,000,000 of its common stock.

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), today announced that Paul A. Meyers, M.D., Chief, Pediatric Sarcoma Service and Vice Chair for Clinical Affairs of Memorial Sloan Kettering Cancer Center, presented a case study of a patient with Ewing sarcoma who achieved a sustained response following treatment with Oncternal’s investigational product candidate, TK216

Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its chief operating officer, Dr. Matthias Schroff, will give a company presentation titled, “Multitargeting Spherical Nucleic Acids: Advantages & Applications,” on Wednesday, September 18, 2019 at 11:40 am GMT at the 2019 International Oligonucleotide and Peptide Conference

Award demonstrates organizations’ commitment to eliminating preventable patient deaths

Envista Holdings Corporation, a subsidiary of Danaher Corporation, announced the pricing of its initial public offering of 26,768,000 shares of its common stock at a price to the public of $22.00 per share.

Gottlieb joins as Aetion advances real-world evidence for making drug development and commercialization more efficient [17-September-2019] NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Today, Aetion , the health care technology company that delivers real-world evidence (RWE) for life sciences companies, payers, and regulatory agencies, announced that former Food and Drug A

TruMed® Systems, the fastest growing vaccine storage and handling company, launched an upgraded model of the emerging standard in vaccine management, AccuVax Vaccine Management System.

DSG, Inc., industry leader in eClinical software and services for life sciences, announced its Version 10 electronic source system integrated with its flagship eCaseLink™ EDC, ePRO and IRT systems, is changing the game for its Phase 1 through 3 sponsor and CRO clients and partners.

Smart pump programming will allow the Medfusion® 4000 pumps to be programmed based on the clinician order, minimizing programming errors.